Sandoz powers up new cell-culture production units to manufacture biopharmaceuticals
Overall investment of EUR 68 million in Austria and Slovenia marks a milestone for Biopharmaceuticals franchise
Kundl (Austria), 4 February 2004 - Sandoz today inaugurated a new manufacturing plant at its Schaftenau site (near Kufstein) in Tyrol, Austria, which has been built to produce innovative biopharmaceuticals. Completed in just two years for an investment of more than EUR 50 million, the new facility further positions Sandoz as a manufacturing partner of choice in this field. Tomorrow, Sandoz' Slovenian affiliate Lek will also open a new biopharmaceutical production facility, the first of its kind in Eastern and Central Europe.
Please see full press release under the following link:
